Original Research
Accepted on 14 Apr 2025
Region-specific neuroprotective effects of meldonium pretreatment in two models of sepsis-associated encephalopathy
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588831
Type at least 3 characters
26,200 articles
Review
Accepted on 14 Apr 2025
Traditional Chinese Medicine for Lupus Nephritis: Modulating Autoimmune Pathogenesis
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1523272
Review
Accepted on 14 Apr 2025
Role and Mechanism of Integrin α5β1 in Bone Formation and Disease
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1494062
Original Research
Accepted on 14 Apr 2025
Magnolia kobus DC. alleviates adenine-induced chronic kidney disease by regulating ferroptosis in C57BL/6 mice
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1548660
Original Research
Accepted on 14 Apr 2025
Stress Signaling and Programmed Cell Death in Breast
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1467504
Original Research
Accepted on 14 Apr 2025
DTGHAT: Multi-molecule heterogeneous graph Transformer based on multi-molecule graph for drug-target identification
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1596216
Clinical Trial
Published on 14 Apr 2025
Effects of esketamine–sufentanil for patient-controlled intravenous analgesia in women following cesarean section: A randomized clinical trial
in Obstetric and Pediatric Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1579633
- 284 views
Original Research
Published on 14 Apr 2025
Integrating traditional omics and machine learning approaches to identify microbial biomarkers and therapeutic targets in pediatric inflammatory bowel disease
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545392
- 318 views
Review
Published on 14 Apr 2025
Integrative approaches to depression in end-stage renal disease: insights into mechanisms, impacts, and pharmacological strategies
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559038
- 264 views
Original Research
Published on 14 Apr 2025
Mirabegron induces selective changes in the faecal microbiota of HFHFr rats without altering bile acid composition
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1547749
- 295 views
Original Research
Published on 14 Apr 2025
Off-label drug use in China after the Physician Law (2021): legal challenges and solutions
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1547418
- 373 views
Original Research
Published on 14 Apr 2025
Global analysis of actionable genomic alterations in thyroid cancer and precision-based pharmacogenomic strategies
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1524623
- 309 views
Systematic Review
Published on 14 Apr 2025
Renal protective effects of vitamin E for drug-induced kidney injury: a meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1461792
- 272 views
Correction
Published on 14 Apr 2025
Corrigendum: Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1604573
- 131 views
Original Research
Published on 14 Apr 2025
Cardiac protection of wogonin in mice with pulmonary fibrosis by regulating Sirt1/ Îł-H2AX pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1551141
- 314 views
Original Research
Published on 14 Apr 2025
Development of an adipocyte differentiation protocol using 3T3-L1 cells for the investigation of the browning process: identification of the PPAR-Îł agonist rosiglitazone as a browning reference drug
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1546456
- 330 views